Literature DB >> 6699411

Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau.

P Aaby, J Bukh, I M Lisse, A J Smits.   

Abstract

Earlier studies have suggested that general measles vaccination programmes should not be made a priority in developing countries because the presumably malnourished children saved from measles are likely to die from something else. Recent community studies indicate, however, that malnutrition is not the cause of high measles mortality. In an urban community in Guinea-Bissau, child mortality has been registered for a period of 3 years; 1 year before and 2 years after the introduction of a general measles vaccination program. In the years following the introduction of measles vaccination, mortality for children aged 6 to 35 months has significantly diminished. Though this is not a controlled study of vaccinated and unvaccinated children, much of the reduced mortality can apparently be attributed to the protective effect of measles vaccination. Children with a history of earlier measles infection had a significantly higher mortality rate than children vaccinated against measles. Rather than being a mechanism of natural selection taking the weakest children, measles apparently aggravates the condition of many children, leading to delayed excess mortality. In areas where the case fatality rate is high, vaccination against measles should be made an indispensable part of primary health care.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699411     DOI: 10.1016/s0163-4453(84)93192-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  28 in total

1.  Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.

Authors:  P Aaby; B Samb; F Simondon; A M Seck; K Knudsen; H Whittle
Journal:  BMJ       Date:  1995-08-19

2.  Nutritional status and delayed mortality following early exposure to measles.

Authors:  P Aaby; M Andersen; K Knudsen
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

Review 3.  Effectiveness of measles vaccination and vitamin A treatment.

Authors:  Christopher R Sudfeld; Ann Marie Navar; Neal A Halsey
Journal:  Int J Epidemiol       Date:  2010-04       Impact factor: 7.196

4.  Measles in developing countries. Part I. Epidemiological parameters and patterns.

Authors:  A R McLean; R M Anderson
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

5.  Decline in measles mortality: nutrition, age at infection, or exposure?

Authors:  P Aaby; J Bukh; I M Lisse; M C da Silva
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-30

6.  Cell mediated immunity after measles in Guinea-Bissau: historical cohort study.

Authors:  S O Shaheen; P Aaby; A J Hall; D J Barker; C B Heyes; A W Shiell; A Goudiaby
Journal:  BMJ       Date:  1996-10-19

7.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

Authors:  Peter Aaby; Cesário L Martins; May-Lill Garly; Carlito Balé; Andreas Andersen; Amabelia Rodrigues; Henrik Ravn; Ida M Lisse; Christine S Benn; Hilton C Whittle
Journal:  BMJ       Date:  2010-11-30

8.  Introduction of measles into a highly immunised West African community: the role of health care institutions.

Authors:  P Aaby; J Bukh; I M Lisse; A J Smits
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

9.  Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.

Authors:  P Aaby; M Andersen; M Sodemann; M Jakobsen; J Gomes; M Fernandes
Journal:  BMJ       Date:  1993-11-20

10.  Vaccination and all-cause child mortality from 1985 to 2011: global evidence from the Demographic and Health Surveys.

Authors:  Mark E McGovern; David Canning
Journal:  Am J Epidemiol       Date:  2015-10-08       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.